References for Chapter III
Antman EM, Harrington RA. Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. JAMA. 2012;308(17):1743-4. PubMed
Atkins D, Best D, Briss PA, Eccles M, et al., GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. PubMed | PMC free article.
Atkins D, Chang S, Gartlehner G, Buckley DI, et al. Chapter 6. Assessing the Applicability of Studies When Comparing Medical Interventions. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(13)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2013. Accessed Nov. 1, 2013 at: http://effectivehealthcare.ahrq.gov/ehc/products/60/318/CER-methods-guide-130916.pdf.
Barker AD, Sigman CC, Kelloff GJ, Hylton NM, et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther. 2009;86(1):97-100. PubMed.
Benson K, Hartz AJ. A comparison of observation studies and randomized, controlled trials. N Engl J Med. 2000;342(25):1878-86. PubMed | Publisher free article.
Berry DA. Bayesian clinical trials. Nat Rev Drug Discov. 2006;5(1):27-36. PubMed.
Boer GJ, Widner H. Clinical neurotransplantation: core assessment protocol rather than sham surgery as control. Brain Res Bull. 2002;58(6):547-53. PubMed.
Briss PA, Zaza S, Pappaioanou M, Fielding J, et al. Developing an evidence-based Guide to Community Preventive Services. Am J Prev Med 2000;18(1S):35-43. PubMed.
Buring JE, Jonas MA, Hennekens CH. Large and simple randomized trials. In Tools for Evaluating Health Technologies: Five Background Papers. US Congress, Office of Technology Assessment, 1995;67-91. BP-H-142. Washington, DC: US Government Printing Office; 1994. Accessed Nov. 1, 2013 at: http://ota-cdn.fas.org/reports/9440.pdf.
Button KS, Ioannidis JP, Mokrysz C, Nosek BA, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365-76. PubMed
Campbell MK, Entwistle VA, Cuthbertson BH, Skea ZC, et al. ; KORAL study group. Developing a placebo-controlled trial in surgery: issues of design, acceptability and feasibility. Trials. 2011;12:50. PubMed | PMC free article.
Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96(3):179-90.PubMed
Chilcott J, Brennan A, Booth A, Karnon J, Tappenden P. The role of modelling in prioritising and planning clinical trials. Health Technol Assess. 2003;7(23):iii,1-125. PubMed | Publisher free article.
Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ. 1996;5(6):513-24. PubMed.
ClinicalTrials.gov. FDAAA 801 Requirements. December 2012. Accessed Aug. 1, 2013 at: http://clinicaltrials.gov/ct2/manage-recs/fdaaa#WhichTrialsMustBeRegistered.
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-92. PubMed | PMC free article.
Croghan TW, Esposito D, Daniel G, Wahl P, Stoto MA. Using medical records to supplement a claims-based comparative effectiveness analysis of antidepressants. Pharmacoepidemiol Drug Saf. 2010;19(8):814-8. PubMed.
de Bruin SR, Baan CA, Struijs JN. Pay-for-performance in disease management: a systematic review of the literature. BMC Health Serv Res. 2011;11:272. PubMed | PMC free article.
de Souza JA, Polite B, Perkins M, Meropol NJ, et al. Unsupported off-label chemotherapy in metastatic colon cancer. BMC Health Serv Res. 2012;12:481. PubMed | PMC free article.
Detsky AS. Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials. Stat Med. 1990;9(1-2):173-84. PubMed.
DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151–85. PubMed.
Djulbegovic B. The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research. Cancer Control. 2009;16(4):342-7. PubMed | PMC free article.
Dreyer NA, Schneeweiss S, McNeil BJ, Berger ML, et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care. 2010;16(6):467-71. PubMed | Publisher free article.
Dreyer NA, Velentgas P, Westrich K, Dubois R. The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution. J Manag Care Pharm. 2014;20(3):301-8. PubMed.
Eisenberg JM. Ten lessons for evidence-based technology assessment. JAMA. 1999; 282(19):1865-9. PubMed.
Eldridge S, Ashby D, Bennett C, et al. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;336(7649):876-80. PubMed | PMC free article.
Ellenberg SS. Do large, simple trials have a place in the evaluation of AIDS therapies? Oncology. 1992;6(4):55-9,63. PubMed.
Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12(3):191-204. PubMed.
Ferguson TB Jr, Peterson ED, Coombs LP, Eiken MC, et al. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: A randomized controlled trial. JAMA. 2003;290(1):49-56. PubMed.
Fishman A, Martinez F, Naunheim K, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003 May 22;348(21):2059-73. PubMed | Publisher free article.
Food and Drug Administration. Adaptive Design Clinical Trials for Drugs and Biologics. ; Draft Guidance. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Rockville, MD, February 2010. Accessed Nov. 1, 2013 at: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm201790.pdf.
Food and Drug Administration. Guidance for Industry. Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. Draft Guidance. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Rockville, MD, December 2012. Accessed Nov. 1, 2013 at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf.
Food and Drug Administration. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Rockville, MD, February5, 2010. Accessed Nov. 1, 2013 at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071121.pdf.
Fourth International Study of Infarct Survival: protocol for a large simple study of the effects of oral mononitrate, of oral capvtopril, and of intravenous magnesium. ISIS-4 collaborative group. Am J Cardiol. 1991;68(14):87D-100D. PubMed.
Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141-5. PubMed.
Friedman LM. Furberg CD, DeMets DL. Fundamentals of Clinical Trials. (4th edition). New York: Springer, 2010.
Fries JF, Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Res Ther. 2004;6(3):R250-5. PubMed | PMC free article.
Fröbert O, Lagerqvist B, Gudnason T, Thuesen L, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042-8. PubMed
Frost J, Okun S, Vaughan T, Heywood J, Wicks P. Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMe. J Med Internet Res. 2011 Jan 21;13(1):e6. PubMed | PMC free article.
Gabler NB, Duan N, Vohra S, Kravitz RL. N-of-1 trials in the medical literature: a systematic review. Med Care. 2011;49(8):761-8. PubMed.
Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. BMJ.2004;328(7430):39-41. PubMed | PMC free article.
Goodman S. A dirty dozen: twelve p-value misconceptions. Semin Hematol. 2008;45(3):135-40. PubMed.
Hartling L, Bond K, Harvey K, Santaguida PL, et al. Developing and Testing a Tool for the Classification of Study Designs in Systematic Reviews of Interventions and Exposures. Agency for Healthcare Research and Quality; December 2010. Methods Research Report. AHRQ Publication No. 11-EHC-007. Bookshelf free publication.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, et al. ; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ. 2011;343:d5928. PubMed | PMC free article
Higgins JPT, Altman DG, Sterne, JAC, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Publisher free publication.
Horng S, Miller FG. Ethical framework for the use of sham procedures in clinical trials. Crit Care Med. 2003;31(suppl. 3):S126-30. PubMed.
Howard L, Thornicroft G. Patient preference randomised controlled trials in mental health research. Br J Psychiatry. 2006;188:303-4. PubMed | Publisher free article.
Howick J, Glasziou P, Aronson JK. The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute? J R Soc Med. 2009;102(5):186-94. PubMed | PMC free article.
Huser V, Cimino JJ. Evaluating adherence to the International Committee of Medical Journal Editors' policy of mandatory, timely clinical trial registration. J Am Med Inform Assoc. 2013;20(e1):e169-74. PubMed | PMC free article.
ICMJE (International Committee of Medical Journal Editors). Clinical Trial Registration. 2014. Accessed Oct. 23, 2014 at: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html.
Institute of Medicine. Committee on Strategies for Small-Number-Participant Clinical Research Trials. Small Clinical Trials: Issues and Challenges. Washington, DC: National Academies Press; 2001. Publisher free book.
Ioannidis JP, Khoury MJ. Are randomized trials obsolete or more important than ever in the genomic era? Genome Med. 2013;5(4):32. PubMed | PMC free article.
Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1-12. PubMed.
Lauer MS. Commentary: How the debate about comparative effectiveness research should impact the future of clinical trials. Stat Med. 2012;31(25):3051-3. PubMed.
Lee JJ, Chu CT. Bayesian clinical trials in action. Stat Med. 2012;31(25):2955-72. PubMed | PMC free article.
Maggioni AP, Franzosi MG, Fresco C, et al. GISSI trials in acute myocardial infarction. Rationale, design, and results. Chest. 1990;97(4 Suppl):146S-150S. PubMed.
Mant D. Can randomized trials inform clinical decisions about individual patients? Lancet. 1999;353:743–6. PubMed.
Mills N, Donovan JL, Wade J, Hamdy FC, et al. Exploring treatment preferences facilitated recruitment to randomized controlled trials. J Clin Epidemiol. 2011;64(10):1127-36. PubMed | PMC free article.
Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17. PubMed.
Moseley JB, O’Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81-8. PubMed | Publisher Free Article.
Nakamura C, Bromberg M, Bhargava S, Wicks P, Zeng-Treitler Q. Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments. J Med Internet Res. 2012;14(3):e90. PubMed | PMC free article.
OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. Publisher free article.
Olivo SA, Macedo LG, Gadotti IC, Fuentes J, et al. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther. 2008;88(2):156-75. PubMed | Publisher free article.
Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol. 1995;48(1):23-40. PubMed.
Piantadosi S. Clinical Trials: A Methodological Perspective (2nd edition). New York: Wiley, 2005.
Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ. 2008;337:a1864. PubMed | PMC free article.
Printz C. I-SPY 2 may change how clinical trials are conducted: Researchers aim to accelerate approvals of cancer drugs. Cancer. 2013;119(11):1925-7. PubMed.
Ramsey SD, Berry K, Etzioni R, et al., National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003;348(21):2092-102. PubMed | Publisher free article.
Rawlins MD. De Testimonio: On the evidence for decisions about the use of therapeutic interventions. The Harveian Oration of 2008. London: Royal College of Physicians, 2008. PubMed.
Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 1994;331(6):394-7. PubMed.
Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B, et al. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol. 2009;62(2):128-37. PubMed.
Roy ASA. Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials. Project FDA Report 5. New York: Manhattan Institute for Policy Research; April 2012. Publisher free article.
Selby JV, Lipstein SH. PCORI at 3 years--progress, lessons, and plans. N Engl J Med. 2014;370(7):592-5. PubMed | Publisher free article.
Silverman WA, Altman DG. Patients' preferences and randomised trials. Lancet. 1996;347(8995):171-4. PubMed.
Spilker B. Guide to Clinical Trials. New York, NY: Raven Press, 1991.
Stone GW, Teirstein PS, Rubenstein R, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39(10):1581-7. PubMed | Publisher free article.
Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003;29(1):15-31. PubMed | Publisher free article.
Temple R. Problems in interpreting active control equivalence trials. Account Res. 1996;4(3-4):267-75. PubMed.
Torgerson DJ, Sibbald B. Understanding controlled trials. What is a patient preference trial? BMJ. 1998;316(7128):360. PubMed | PMC free article.
Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-32. PubMed.
US Preventive Services Task Force Procedure Manual. December, 2015. Accessed June 7, 2016 at:http://www.uspreventiveservicestaskforce.org/Home/GetFile/6/7/procedure-manual_2016/pdf .
van der Graaf R, Roes KC, van Delden JJ. Adaptive trials in clinical research: scientific and ethical issues to consider. JAMA. 2012;307(22):2379-80. PubMed.
Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med. 1997;337(14):1003-5. PubMed.
Veatch RM. The irrelevance of equipoise. J Med Philos. 2007;32(2):167-83. PubMed.
Viswanathan M, Ansari MT, Berkman ND, Chang S, et al. Chapter 9. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality. January 2014. Accessed Feb. 1, 2014 at: http://www.effectivehealthcare.ahrq.gov/ehc/products/60/318/CER-Methods-Guide-140109.pdf.
Walach H, Falkenberg T, Fønnebø V, Lewith G, Jonas WB. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol. 2006;24;6:29. PubMed | PMC free article.
Wang R, Lagakos WE, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine: reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357(21):2189-94. PubMed | Publisher free article.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, et al. ; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. PubMed.
Yusuf S, Held P, Teo KK, Toretsky ER. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med. 1990;9(1-2):73-83. PubMed.
Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database--update and key issues. N Engl J Med. 2011;364(9):852-60. PubMed | PMC free article.